Theravance Biopharma
TBPH
#6918
Rank
S$0.61 B
Marketcap
Country
$12.39
Share price
-0.86%
Change (1 day)
1.70%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Cash on Hand
Cash on Hand as of December 2024 : S$0.11 Billion
According to Theravance Biopharma
's latest financial reports the company has S$0.11 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Theravance Biopharma - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$0.12 B | -11.22% |
| 2023-12-31 | S$0.13 B | -69.19% |
| 2022-12-31 | S$0.43 B | 87.21% |
| 2021-12-31 | S$0.23 B | -39.49% |
| 2020-12-31 | S$0.38 B | 2.36% |
| 2019-12-31 | S$0.37 B | -45.15% |
| 2018-12-31 | S$0.69 B | 48.06% |
| 2017-12-31 | S$0.46 B | -35.72% |
| 2016-12-31 | S$0.72 B | 197.33% |
| 2015-12-31 | S$0.24 B | -27.5% |
| 2014-12-31 | S$0.33 B | |
| 2013-12-31 | N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | S$0.21 B | 84.23% | 🇺🇸 USA |
 | S$0.51 B | 333.88% | 🇺🇸 USA |
 | S$0.69 B | 485.80% | 🇺🇸 USA |
 | S$0.44 B | 279.17% | 🇺🇸 USA |